New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
Microbiota is considered an independent organ with the capability to modulate tumor growth and response to therapies. In the chemo-free era, the use of new immunotherapies, more selective and effective and less toxic, led to the extension of overall survival of patients, subject to their ability to...
Main Authors: | Vanessa Innao, Andrea Gaetano Allegra, Caterina Musolino, Alessandro Allegra |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/23/8902 |
Similar Items
-
CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
by: Delong Liu
Published: (2019-11-01) -
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
by: Vanessa Innao, et al.
Published: (2021-12-01) -
The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges
by: Youssef Bouferraa, et al.
Published: (2021-07-01) -
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
by: Negar Hosseinkhani, et al.
Published: (2020-11-01) -
The Impact of Immunological Checkpoint Inhibitors and Targeted Therapy on Chronic Pruritus in Cancer Patients
by: Alessandro Allegra, et al.
Published: (2021-12-01)